Loan & DebtJun 22, 2026, 05:22 PM
NeoGenomics Issues $316.25M Convertible Senior Notes Due 2032
AI Summary
NeoGenomics, Inc. completed its offering of 0.75% Convertible Senior Notes due 2032, totaling $316.25 million in aggregate principal amount after initial purchasers exercised their option for additional notes. The notes have an initial conversion price of approximately $14.16 per share, representing a 35.0% premium over the last reported sale price. To mitigate potential dilution and offset cash payments upon conversion, the company also entered into capped call transactions with a cap price of $20.98 per share.
Key Highlights
- Issued $316.25 million in aggregate principal amount of 0.75% Convertible Senior Notes due 2032.
- Notes bear interest at 0.75% per annum, payable semiannually.
- Notes mature on July 1, 2032, unless earlier converted, redeemed, or repurchased.
- Initial conversion price is approximately $14.16 per share, a 35.0% premium.
- Entered into capped call transactions with a cap price of $20.98 per share.
- Capped call transactions aim to reduce potential dilution and/or offset cash payments.
- Company may redeem notes on or after July 6, 2029, under certain conditions.
Price Impact
More from NEO